IRIS
ABELTINO, Manuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 631
NA - Nord America 516
AS - Asia 295
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 500
CN - Cina 226
SE - Svezia 165
IT - Italia 154
FI - Finlandia 101
IE - Irlanda 97
TR - Turchia 49
DE - Germania 41
UA - Ucraina 22
CA - Canada 16
RO - Romania 16
BE - Belgio 14
AT - Austria 9
VN - Vietnam 8
IN - India 5
SG - Singapore 5
GB - Regno Unito 4
CZ - Repubblica Ceca 2
DK - Danimarca 2
ES - Italia 2
CH - Svizzera 1
CM - Camerun 1
EU - Europa 1
IR - Iran 1
NL - Olanda 1
PK - Pakistan 1
Totale 1.444
Salva come PNG Salva come JPEG
Città #
Dublin 97
Chandler 91
Ann Arbor 85
Jacksonville 54
Parma 48
Izmir 41
Nanjing 40
Beijing 36
Ashburn 31
Dearborn 31
San Mateo 21
Shanghai 18
Focsani 16
Princeton 16
Toronto 16
Nanchang 15
Shenyang 15
Brussels 14
Falls Church 14
Kunming 14
Jinan 13
Des Moines 10
Wilmington 10
Bologna 8
Dong Ket 8
Hebei 8
Jiaxing 8
Kocaeli 8
New York 8
Vienna 8
Düsseldorf 7
Hangzhou 7
Arzano 6
Bremen 6
Changsha 6
Hefei 6
Helsinki 6
Piacenza 6
Redmond 6
Cambridge 5
Taizhou 5
Verona 5
Boardman 4
Langhirano 4
Novara 4
Reggio Emilia 4
Savignano Sul Rubicone 4
Seattle 4
Tianjin 4
Woodbridge 4
Chengdu 3
Los Angeles 3
Modena 3
Mountain View 3
Reggio Nell'emilia 3
Zhengzhou 3
Frederiksberg 2
Fremont 2
Fuzhou 2
Gurgaon 2
Leawood 2
Madrid 2
Marghera 2
Mestre 2
Orange 2
Padova 2
Pune 2
Redwood City 2
Rockville 2
Sala Baganza 2
Treviso 2
Walnut 2
Abbiategrasso 1
Ahmedabad 1
Amsterdam 1
Ardabil 1
Bari 1
Brno 1
Böblingen 1
Chongqing 1
Council Bluffs 1
Dallas 1
Fidenza 1
Guangzhou 1
Haikou 1
Jinhua 1
Monza 1
Nanning 1
Ningbo 1
Norwalk 1
Palermo 1
Petilia Policastro 1
Pontedera 1
Prilly 1
Puxian 1
Sorbolo 1
Taiyuan 1
Urbino 1
Washington 1
Wuhan 1
Totale 983
Salva come PNG Salva come JPEG
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 196
The Pharmacological Blockade of Phosphodiesterase IV Potentiates the Anti-Tumor Effects of Arsenic Trioxide (ATO) in Acute Myelogenous Leukemia Cells through Multiple Signaling Pathways 117
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 109
Are the Myeloma bone microevironment cells tumoral or not? 94
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment 89
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 89
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 84
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules 83
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 82
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 81
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 72
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 72
Non canonical wnt signal pathway (Wnt5a/ror2) activation stimulates the osteogenic differentiation process of bone mesenchymal cells being a potential target in multiple myeloma bone disease 66
Increased osteocyte apoptosis in Multiple Myeloma patients: a potential role in bone remodeling alterations related to osteolytic bone lesions 63
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 61
Myeloma cells inhibit the non-canonical wnt co-receptor ror2 in human mesenchymal/osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on mm-induced impairment of the osteogenic differentiation process 61
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 38
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 23
Totale 1.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.511
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201956 0 0 0 0 0 0 0 0 0 0 43 13
2019/2020325 55 51 18 3 19 33 37 12 23 36 16 22
2020/2021197 1 16 5 1 47 16 3 8 48 15 21 16
2021/2022179 5 8 4 31 9 10 20 18 9 11 25 29
2022/2023402 56 53 35 26 46 29 14 9 110 5 15 4
2023/2024162 17 13 13 7 24 38 19 9 7 15 0 0
Totale 1.480